CYPHERPUNK TECHNOLOGIES INC

Cypherpunk’s new RSU grant signals long‑term value focus, sparking a 380% social‑media spike while the stock edges upward – a bullish sign for investors.

CypherPunk’s insider RSU sale shows routine equity liquidity, not a signal of weakness, while the biotech’s oncology pipeline and market‑access strategy remain key to future growth.

Cypherpunk’s chief investment officer buys 16.6 million shares, backing the firm’s Zcash mining pivot and boosting its 31 % stake.

Insider sales at CYPHERPUNK TECHNOLOGIES INC reveal a shift toward liquidity, not doubt, amid growing social‑media buzz and potential upside from Ethereum‑focused growth.